• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The use of radioactive 7 alpha, 17 alpha-dimethyl-19-nortestosterone (mibolerone) in the assay of androgen receptors.

作者信息

Schilling K, Liao S

出版信息

Prostate. 1984;5(6):581-8. doi: 10.1002/pros.2990050603.

DOI:10.1002/pros.2990050603
PMID:6333679
Abstract

Tritiated 7 alpha, 17 alpha-dimethyl-19-nortestosterone (DMNT; mibolerone), a synthetic androgen stable to metabolic conversion in the rat ventral prostate, is an excellent radioactive ligand for the quantitation and characterization of androgen receptors in prostate, liver, and cultured cells. DMNT is more receptor-selective than 17 alpha-methyl-17 beta-hydroxy-estra-4,9,11-trien-3-one (R1881); DMNT interacts with glucocorticoid and progestin receptors much less strongly than R1881. Unlike 5 alpha-dihydrotestosterone, DMNT does not bind tightly to testosterone-estradiol binding globulin of human serum. The hydroxylapatite-filter assay we employed can clearly distinguish between DMNT binding to androgen receptors of rat ventral prostate and interaction of DMNT with androgen binding protein of epididymides. The prostate cytosol (3H)DMNT-receptor complex sediments in two forms (4 and 8 S) in a low salt medium. In 0.4 M KCl, both the prostate cytosol and nuclear (3H)DMNT-receptor complexes migrated as 3-4 S components. The formation of both the cytosol and nuclear DMNT-receptor complexes is inhibited by antiandrogens and 17 beta-estradiol.

摘要

相似文献

1
The use of radioactive 7 alpha, 17 alpha-dimethyl-19-nortestosterone (mibolerone) in the assay of androgen receptors.
Prostate. 1984;5(6):581-8. doi: 10.1002/pros.2990050603.
2
Binding of 7 alpha, 17 alpha-dimethyl-19-nortestosterone (mibolerone) to androgen and progesterone receptors in human and animal tissues.
Endocrinology. 1986 Apr;118(4):1327-33. doi: 10.1210/endo-118-4-1327.
3
Characterization of steroid receptors in human prostate using mibolerone.
Prostate. 1986;8(3):241-53. doi: 10.1002/pros.2990080305.
4
Characterization of the cytosol androgen receptor of the human prostate.人前列腺胞质雄激素受体的特性研究
J Clin Endocrinol Metab. 1983 Jan;56(1):113-20. doi: 10.1210/jcem-56-1-113.
5
Binding of mibolerone to androgen receptor of benign hypertrophic human prostate. Comparison with R1881.
Endocrinol Jpn. 1985 Feb;32(1):141-52. doi: 10.1507/endocrj1954.32.141.
6
[Comparison of the binding nature of mibolerone to androgen receptor of human prostate with that of R1881].
Nihon Naibunpi Gakkai Zasshi. 1988 Aug 20;64(8):655-65. doi: 10.1507/endocrine1927.64.8_655.
7
Androgen receptor binding characteristics in the cytosol of the rat dorsolateral prostate gland and the Dunning R-3327 prostatic adenocarcinoma.大鼠背外侧前列腺和邓宁R-3327前列腺腺癌细胞质中的雄激素受体结合特性。
Prostate. 1984;5(1):101-11. doi: 10.1002/pros.2990050110.
8
Characterization of a [3H]methyltrienolone (R1881) binding protein in rat liver cytosol.
J Steroid Biochem. 1985 Feb;22(2):211-9. doi: 10.1016/0022-4731(85)90114-1.
9
Use of a new radioactive ligand, 7 alpha, 17 alpha-dimethyl[17 alpha-methyl 3H]19-nortestosterone for the estimation of androgen receptors in rat liver cytosol.
J Steroid Biochem. 1985 Jul;23(1):121-3. doi: 10.1016/0022-4731(85)90270-5.
10
Determination of androgen receptors in human benign prostatic hypertrophy with two synthetic radiolabeled ligands.
Urol Int. 1986;41(2):133-8. doi: 10.1159/000281182.

引用本文的文献

1
Selective Glucocorticoid Receptor Modulators (SGRMs) Delay Castrate-Resistant Prostate Cancer Growth.选择性糖皮质激素受体调节剂(SGRMs)可延缓去势抵抗性前列腺癌的生长。
Mol Cancer Ther. 2017 Aug;16(8):1680-1692. doi: 10.1158/1535-7163.MCT-16-0923. Epub 2017 Apr 20.
2
Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies.发现新一代雄激素受体抑制剂ODM-201,其针对雄激素信号导向的前列腺癌治疗的耐药机制。
Sci Rep. 2015 Jul 3;5:12007. doi: 10.1038/srep12007.
3
Autoimmune anti-androgen-receptor antibodies in human serum.
人血清中的自身免疫性抗雄激素受体抗体。
Proc Natl Acad Sci U S A. 1985 Dec;82(24):8345-8. doi: 10.1073/pnas.82.24.8345.
4
A possible explanation for the peripheral selectivity of a novel non-steroidal pure antiandrogen, Casodex (ICI 176,334).新型非甾体类纯抗雄激素药物康士得(ICI 176,334)外周选择性的一种可能解释。
Br J Cancer. 1989 Nov;60(5):664-8. doi: 10.1038/bjc.1989.336.
5
Soluble and nuclear type I and II androgen-binding sites in benign hyperplasia and cancer of the human prostate.人前列腺良性增生和癌中可溶性及核内I型和II型雄激素结合位点
Urol Res. 1992;20(2):127-32. doi: 10.1007/BF00296524.